123 related articles for article (PubMed ID: 23958207)
41. Nuclear transport of Ras-associated tumor suppressor proteins: different transport receptor binding specificities for arginine-rich nuclear targeting signals.
Kumari G; Singhal PK; Rao MR; Mahalingam S
J Mol Biol; 2007 Apr; 367(5):1294-311. PubMed ID: 17320110
[TBL] [Abstract][Full Text] [Related]
42. [Recent advances on relationship between phospholipase C epsilon-1 gene and tumor].
Cui XB; Chen YZ; Li F
Zhonghua Bing Li Xue Za Zhi; 2012 Mar; 41(3):213-6. PubMed ID: 22800494
[No Abstract] [Full Text] [Related]
43. SARAH Domain-Mediated MST2-RASSF Dimeric Interactions.
Sánchez-Sanz G; Tywoniuk B; Matallanas D; Romano D; Nguyen LK; Kholodenko BN; Rosta E; Kolch W; Buchete NV
PLoS Comput Biol; 2016 Oct; 12(10):e1005051. PubMed ID: 27716844
[TBL] [Abstract][Full Text] [Related]
44. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3.
Dammann R; Li C; Yoon JH; Chin PL; Bates S; Pfeifer GP
Nat Genet; 2000 Jul; 25(3):315-9. PubMed ID: 10888881
[TBL] [Abstract][Full Text] [Related]
45. Frequent epigenetic inactivation of RASSF1A and BLU genes located within the critical 3p21.3 region in gliomas.
Hesson L; Bièche I; Krex D; Criniere E; Hoang-Xuan K; Maher ER; Latif F
Oncogene; 2004 Mar; 23(13):2408-19. PubMed ID: 14743209
[TBL] [Abstract][Full Text] [Related]
46. LOT1 (ZAC1/PLAGL1) and its family members: mechanisms and functions.
Abdollahi A
J Cell Physiol; 2007 Jan; 210(1):16-25. PubMed ID: 17063461
[TBL] [Abstract][Full Text] [Related]
47. RASSF1A Signaling in the Heart: Novel Functions beyond Tumor Suppression.
Del Re DP; Sadoshima J
Mol Biol Int; 2012; 2012():154283. PubMed ID: 22577551
[TBL] [Abstract][Full Text] [Related]
48. NORE1A, a homologue of RASSF1A tumour suppressor gene is inactivated in human cancers.
Hesson L; Dallol A; Minna JD; Maher ER; Latif F
Oncogene; 2003 Feb; 22(6):947-54. PubMed ID: 12584574
[TBL] [Abstract][Full Text] [Related]
49. [The RASSF1 (Ras association domain family protein 1) gene. Category: tumor suppressor gene].
Bull Cancer; 2005 Nov; 92(11):931-2. PubMed ID: 16316825
[No Abstract] [Full Text] [Related]
50. Phospholipase Cepsilon guanine nucleotide exchange factor activity and activation of Rap1.
Satoh T; Edamatsu H; Kataoka T
Methods Enzymol; 2006; 407():281-90. PubMed ID: 16757332
[TBL] [Abstract][Full Text] [Related]
51. The tumour suppressor RASSF1A is a novel substrate of PKC.
Verma SK; Ganesan TS; Parker PJ
FEBS Lett; 2008 Jun; 582(15):2270-6. PubMed ID: 18514071
[TBL] [Abstract][Full Text] [Related]
52. RASSF3 and NORE1: identification and cloning of two human homologues of the putative tumor suppressor gene RASSF1.
Tommasi S; Dammann R; Jin SG; Zhang XF; Avruch J; Pfeifer GP
Oncogene; 2002 Apr; 21(17):2713-20. PubMed ID: 11965544
[TBL] [Abstract][Full Text] [Related]
53. PLCε signaling in cancer.
Zhang RY; Du WQ; Zhang YC; Zheng JN; Pei DS
J Cancer Res Clin Oncol; 2016 Apr; 142(4):715-22. PubMed ID: 26109147
[TBL] [Abstract][Full Text] [Related]
54. INK4 proteins, a family of mammalian CDK inhibitors with novel biological functions.
Cánepa ET; Scassa ME; Ceruti JM; Marazita MC; Carcagno AL; Sirkin PF; Ogara MF
IUBMB Life; 2007 Jul; 59(7):419-26. PubMed ID: 17654117
[TBL] [Abstract][Full Text] [Related]
55. p53FamTaG: a database resource of human p53, p63 and p73 direct target genes combining in silico prediction and microarray data.
Sbisà E; Catalano D; Grillo G; Licciulli F; Turi A; Liuni S; Pesole G; De Grassi A; Caratozzolo MF; D'Erchia AM; Navarro B; Tullo A; Saccone C; Gisel A
BMC Bioinformatics; 2007 Mar; 8 Suppl 1(Suppl 1):S20. PubMed ID: 17430565
[TBL] [Abstract][Full Text] [Related]
56. Mitotic kinase Aurora-A phosphorylates RASSF1A and modulates RASSF1A-mediated microtubule interaction and M-phase cell cycle regulation.
Rong R; Jiang LY; Sheikh MS; Huang Y
Oncogene; 2007 Dec; 26(55):7700-8. PubMed ID: 17563743
[TBL] [Abstract][Full Text] [Related]
57. Regulation of RASSF by non-coding RNAs in different cancers: RASSFs as masterminds of their own destiny as tumor suppressors and oncogenes.
Farooqi AA; Kapanova G; Kussainov AZ; Datkhayeva Z; Raganina K; Sadykov BN
Noncoding RNA Res; 2022 Jun; 7(2):123-131. PubMed ID: 35702574
[TBL] [Abstract][Full Text] [Related]
58. Protein kinase A-mediated phosphorylation of the RASSF1A tumour suppressor at Serine 203 and regulation of RASSF1A function.
Richter AM; Schagdarsurengin U; Rastetter M; Steinmann K; Dammann RH
Eur J Cancer; 2010 Nov; 46(16):2986-95. PubMed ID: 20655196
[TBL] [Abstract][Full Text] [Related]
59. CpG island promoter hypermethylation of a novel Ras-effector gene RASSF2A is an early event in colon carcinogenesis and correlates inversely with K-ras mutations.
Hesson LB; Wilson R; Morton D; Adams C; Walker M; Maher ER; Latif F
Oncogene; 2005 Jun; 24(24):3987-94. PubMed ID: 15806169
[TBL] [Abstract][Full Text] [Related]
60. The Emerging Roles of RASSF5 in Human Malignancy.
Li S; Teng J; Li H; Chen F; Zheng J
Anticancer Agents Med Chem; 2018; 18(3):314-322. PubMed ID: 28356010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
